Recent Finacing
Recent Raise
Otologic Pharmaceutics is a development-stage Oklahoma City biopharmaceutical company developing oral and other pharmacological therapeutics, including lead candidate HPN1010 (NHPN‑1010), to treat inner-ear and hearing disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
